Vanda Pharmaceuticals | Capital Ordinário





Capital Ordinário Alterar Data
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Agios Pharmaceuticals USD 58.28M 241K 2025-09
Akebia Therapeutics USD 2K 0 2025-03
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
Anika Therapeutics USD 143K 1000 2025-03
Arrowhead Research USD 135.7M 2.44M 2025-09
AstraZeneca USD 1.55B 206K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Enanta Pharmaceuticals USD 212K 1000 2023-12
Esperion Therapeutics USD 112K 11K 2023-09
Halozyme Therapeutics USD 117.52M 98K 2025-09
Heron Therapeutics USD 1.52M 14K 2024-09
Insmed USD 212.58M 210.76M 2025-09
J&J USD 2.41B 584K 2025-09
Ligand Pharmaceuticals USD 20K 0 2025-03
Merck USD 2.49B 15.79M 2025-09
Minerva Neurosciences USD 1000 0 2024-09
Moderna USD 391M 2M 2025-09
Novartis USD 1.92B 17.06M 2025-09
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 79.93M 554K 2025-09
Puma Biotechnology USD 5K 0 2024-06
Takeda JPY 1.58B 2K 2025-12
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12
Veracyte USD 78.67M 73K 2025-09


Vanda Pharmaceuticals Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.